CS100192A3 - Piperidine derivatives, process of their preparation and a pharmaceuticalcomposition containing said derivatives - Google Patents

Piperidine derivatives, process of their preparation and a pharmaceuticalcomposition containing said derivatives Download PDF

Info

Publication number
CS100192A3
CS100192A3 CS921001A CS100192A CS100192A3 CS 100192 A3 CS100192 A3 CS 100192A3 CS 921001 A CS921001 A CS 921001A CS 100192 A CS100192 A CS 100192A CS 100192 A3 CS100192 A3 CS 100192A3
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
group
carbon atoms
compounds
Prior art date
Application number
CS921001A
Other languages
Czech (cs)
English (en)
Inventor
Samir Jegham
Gerard Defosse
Thomas Purcell
Johannes Schoemaker
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of CS100192A3 publication Critical patent/CS100192A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Peptides Or Proteins (AREA)
CS921001A 1991-04-03 1992-04-02 Piperidine derivatives, process of their preparation and a pharmaceuticalcomposition containing said derivatives CS100192A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9104009A FR2674855B1 (fr) 1991-04-03 1991-04-03 Derives de piperidine, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
CS100192A3 true CS100192A3 (en) 1992-10-14

Family

ID=9411394

Family Applications (1)

Application Number Title Priority Date Filing Date
CS921001A CS100192A3 (en) 1991-04-03 1992-04-02 Piperidine derivatives, process of their preparation and a pharmaceuticalcomposition containing said derivatives

Country Status (19)

Country Link
US (1) US5280030A (de)
EP (1) EP0507650B1 (de)
JP (1) JPH0788378B2 (de)
KR (1) KR920019778A (de)
CN (1) CN1065459A (de)
AT (1) ATE138375T1 (de)
AU (1) AU646332B2 (de)
CA (1) CA2064924A1 (de)
CS (1) CS100192A3 (de)
DE (1) DE69210875T2 (de)
FI (1) FI921459L (de)
FR (1) FR2674855B1 (de)
HU (1) HUT62573A (de)
IE (1) IE921048A1 (de)
IL (1) IL101472A0 (de)
MX (1) MX9201507A (de)
NO (1) NO921281L (de)
NZ (1) NZ242214A (de)
PL (1) PL294088A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993014745A1 (en) * 1992-01-23 1993-08-05 Smithkline Beecham Plc Use of 5-ht4 receptor antagonists as medicaments for treating migraine
US5380858A (en) * 1992-04-01 1995-01-10 The University Of Toledo Process for the preparation of intermediates useful for the synthesis of histamine receptor antagonists
FR2696176B1 (fr) * 1992-09-28 1994-11-10 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
FR2710915B1 (fr) * 1993-10-04 1995-11-24 Synthelabo Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
FR2731708B1 (fr) * 1995-03-13 1997-04-30 Synthelabo Derives de piperidine, leur procede de preparation et leur application en therapeutique
FR2731707B1 (fr) * 1995-03-13 1997-04-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2765221B1 (fr) * 1997-06-25 1999-07-30 Synthelabo Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique
FR2765580B1 (fr) * 1997-07-01 1999-08-06 Synthelabo Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique
FR2772377B1 (fr) * 1997-12-12 2000-01-07 Synthelabo Derives de 1-(1-h-imidazol-2-yl)pyrrolidines et 1-(1-h-imidazol-2-ylpiperidines), leur preparation et leur application en therapeutique
GB9918425D0 (en) * 1999-08-04 1999-10-06 Novartis Ag Organic compounds
US6887870B1 (en) * 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
AU2002346216B2 (en) * 1999-12-27 2005-12-08 Japan Tobacco Inc. Fused cyclic compounds and medicinal use thereof
CZ20013424A3 (cs) * 1999-12-27 2002-02-13 Japan Tobacco Inc. Sloučeniny s fúzovanými kruhy a jejich pouľití jako léčiva
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
AR035543A1 (es) * 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
BRPI0413234A (pt) * 2003-08-01 2006-10-03 Genelabs Tech Inc derivados de imidazola bicìclica contra flaviviridae
CN101103026A (zh) * 2005-01-14 2008-01-09 健亚生物科技公司 用于治疗病毒感染的吲哚衍生物
US8816090B2 (en) 2005-02-25 2014-08-26 Pfizer Inc. Benzisoxazole derivatives
EP2579873A4 (de) * 2010-06-11 2013-11-27 Merck Sharp & Dohme Neuartige prolylcarboxypeptidase-hemmer
EP2688648B1 (de) 2011-03-23 2016-01-06 RaQualia Pharma Inc. 5-ht4-rezeptoragonist als prokinetischer wirkstoff
US20150197503A1 (en) * 2012-07-27 2015-07-16 Bial-Portela & Cª, S.A. Process for the synthesis of substituted urea compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
FR2579596B1 (fr) * 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
DE3877406T2 (de) * 1987-04-28 1993-06-09 Fujisawa Astra Ltd Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
FR2658823B1 (fr) * 1990-02-27 1992-04-30 Adir Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent .

Also Published As

Publication number Publication date
ATE138375T1 (de) 1996-06-15
DE69210875T2 (de) 1996-12-05
FI921459A0 (fi) 1992-04-02
PL294088A1 (de) 1993-02-08
FR2674855B1 (fr) 1994-01-14
AU646332B2 (en) 1994-02-17
NO921281D0 (no) 1992-04-02
EP0507650A1 (de) 1992-10-07
US5280030A (en) 1994-01-18
FR2674855A1 (fr) 1992-10-09
CN1065459A (zh) 1992-10-21
NZ242214A (en) 1993-05-26
KR920019778A (ko) 1992-11-20
NO921281L (no) 1992-10-05
HU9201116D0 (en) 1992-06-29
FI921459A7 (fi) 1992-10-04
DE69210875D1 (de) 1996-06-27
IL101472A0 (en) 1992-12-30
MX9201507A (es) 1992-10-01
EP0507650B1 (de) 1996-05-22
JPH05112563A (ja) 1993-05-07
HUT62573A (en) 1993-05-28
CA2064924A1 (en) 1992-10-04
FI921459L (fi) 1992-10-04
JPH0788378B2 (ja) 1995-09-27
IE921048A1 (en) 1992-10-07
AU1398992A (en) 1992-10-08

Similar Documents

Publication Publication Date Title
AU646332B2 (en) Piperidine derivatives, their preparation and their therapeutic application
DE69729583T2 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
US5985896A (en) Piperidine and morpholine derivatives and their use as therapeutic agents
SK103293A3 (en) Piperidine derivatives, process for their preparation and pharmaceutical compositions containing these derivatives
MXPA06013113A (es) Derivados de tetrahidronaftiridina utiles como ligandos del receptor h3 de histamina.
KR20030008151A (ko) 이미다조피리딘 및 이미다조피리미딘 항바이러스제
JP2011529964A (ja) 抗菌剤としての尿素誘導体
JPH11512443A (ja) 新規な置換アザ環式またはアザ二環式化合物
WO2008097819A2 (en) Chemical compounds
WO2008024196A1 (en) Chemical compounds
AU2009352490B2 (en) 1, 2-dihydro-2-oxoquinoline compounds as 5-HT 4 receptor ligands
AU2018223982A1 (en) 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors
AU2009267159A1 (en) Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
EP3700895B1 (de) Polycyclische amide als muscarin-m1-rezeptor-positive allosterische modulatoren
AU658533B2 (en) Piperidine derivatives, their preparation and their application in therapy
NZ239516A (en) Substituted pyrido[4,3-d]pyrimidine derivative, preparation and pharmaceutical compositions thereof
WO2017004609A1 (en) Thiadiazole modulators of s1p and methods of making and using
CA2132849A1 (en) Bridged bis-aryl carbinol derivatives, compositions and methods of use
JP6301474B2 (ja) 癌および炎症性疾患を処置するための新規化合物
US6211204B1 (en) Muscarinic receptor agonists
JP6276852B2 (ja) 新規化合物、使用およびそれらの調製のための方法
JPH05502235A (ja) イミダゾール類
HU201075B (en) Process for producing 2-((piperidin-4-yl)-methyl)-benzofuro)2,3-c)- pyridine derivatives and pharmaceutical compositions containing them